Catalyst Wire Dossier Catalyst Wire Dossier

Seqirus A/H7N9 IIV

inactivated influenza vaccine targeting A/H7N9 · Seqirus
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Seqirus A/H7N9 IIV, covering 2021-05-17 to 2021-05-17. Get the full timeline:

Most recent: Clinical Trial Update: Safety/Efficacy Study of Seqirus A/H7N9 IIV With or Without MF59(R) Adjuvant to Prevent Avian Influenza [Phase 2]

See pricing